Home
About
Overview
Sharing Data
ORCID
Help
History (3)
In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors.
Porosity
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
In vivo ubiquitination and proteasome-mediated degradation of p53(1).
In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 1996 Jun 01; 56(11):2649-54.
View in:
PubMed
subject areas
Acetylcysteine
Cells, Cultured
Cyclin-Dependent Kinase Inhibitor p21
Cyclins
Cysteine Endopeptidases
Cysteine Proteinase Inhibitors
Gene Expression
Humans
Leupeptins
Multienzyme Complexes
Proteasome Endopeptidase Complex
RNA, Messenger
Tumor Suppressor Protein p53
Ubiquitins
authors with profiles
Carl G Maki